Vol. 55 No. 2 (2016): Acta Oncologica

Articles

• Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study

  Tuuli Soini, Ritva Hurskainen, Seija Grénman, Johanna Mäenpää, Jorma Paavonen, Heikki Joensuu, Eero Pukkala

  188-192

  Published: 2016-02-01

  • PDF

• Unsustained response to brentuximab as single agent therapy in a patient with CD30 positive angiosarcoma

  Maibritt P. Holm, Karin Hjorthaug, Steen Bærentzen, Akmal A. Safwat

  251-253

  Published: 2016-02-01

  • PDF

• A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial

  Simon Ekman, Johan Harmenberg, Jan-Erik Frödin, Stefan Bergström, Cecilia Wassberg, Staffan Eksborg, Olle Larsson, Magnus Axelson, Markus Jerling, Lars Abrahmsen, Åsa Hedlund, Carina Alvfors, Birgitta Ståhl, Michael Bergqvist

  140-148

  Published: 2016-02-01

  • PDF
  • Supplemental Material

• Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer – a population-based study

  Satyamurthy Anuradha, Peter J. Donovan, Penelope M. Webb, Alison H. Brand, Jeffrey Goh, Michael Friedlander, Martin K. Oehler, Michael Quinn, Christopher Steer, Susan J. Jordan

  226-233

  Published: 2016-02-01

  • PDF

• Peer support and additional information in group medical consultations (GMCs) for BRCA1/2 mutation carriers: A randomized controlled trial

  Annemiek Visser, Hanneke W. M. van Laarhoven, Gwendolyn H. Woldringh, Nicoline Hoogerbrugge, Judith B. Prins

  178-187

  Published: 2016-02-01

  • PDF

• Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision making

  Marleen Kunneman, Ellen G. Engelhardt, F. L. (Laura) ten Hove, Corrie A. M. Marijnen, Johanneke E. A. Portielje, Ellen M. A. Smets, Hanneke J. C. J. M. (Hanneke) de Haes, Anne M. Stiggelbout, Arwen H. Pieterse

  134-139

  Published: 2016-02-01

  • PDF

• A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group

  Louise Faaborg, Isa Niemann, Eva B. Ostenfeld, Estrid S. Hansen, Lone Sunde, Jacob C. Lindegaard

  234-239

  Published: 2016-02-01

  • PDF

• Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer

  Mette Pøhl, Karen Ege Olsen, Rene Holst, Tom Donnem, Lill-Tove Busund, Roy M. Bremnes, Samer Al-Saad, Sigve Andersen, Elin Richardsen, Henrik J. Ditzel, Olfred Hansen

  167-177

  Published: 2016-02-01

  • PDF

• Setup error and motion during deep inspiration breath-hold breast radiotherapy measured with continuous portal imaging

  Christina Maria Lutz, Per Rugaard Poulsen, Walther Fledelius, Birgitte Vrou Offersen, Mette Skovhus Thomsen

  193-200

  Published: 2016-02-01

  • PDF

• Minimally invasive procedures for the management of vertebral bone pain due to cancer: The EAPC recommendations

  Sebastiano Mercadante, Pål Klepstad, Geana Paula Kurita, Per Sjøgren, Alessandra Pigni, Augusto Caraceni

  129-133

  Published: 2016-02-01

  • PDF

• Tangential IMRT versus TomoTherapy with and without breath-hold in left-sided whole breast irradiation

  Mirjam Mast, Truus Reynders, Mark Heijenbrok, Loes van Kempen-Harteveld, Hilde Van Parijs, Hans Rozema, Anna Petoukhova, Dirk Verellen, Mark De Ridder, Henk Struikmans

  240-243

  Published: 2016-02-01

  • PDF

• Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer

  Takanori Abe, Katsuyuki Shirai, Jun-Ichi Saitoh, Takeshi Ebara, Hirofumi Shimada, Mutsumi Tashiro, Naoko Okano, Tatsuya Ohno, Takashi Nakano

  163-166

  Published: 2016-02-01

  • PDF

• The influence of hyperglycemia during radiotherapy on survival in patients with primary glioblastoma

  Sebastian Adeberg, Denise Bernhardt, Robert Foerster, Tilman Bostel, Stefan Alexander Koerber, Angela Mohr, Christian Koelsche, Stefan Rieken, Juergen Debus

  201-207

  Published: 2016-02-01

  • PDF

• Does shared decision making exist in oncologic practice?

  Bengt Glimelius, Nina Cavalli-Björkman

  125-128

  Published: 2016-02-01

  • PDF

• Is 18F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?

  Marina Orevi, Nanette Freedman, Esther Tahover, Beatrice Uziely, Roland Chisin, Tamar Peretz, Martine Klein

  244-247

  Published: 2016-02-01

  • PDF

• Quantification of CT-assessed radiation-induced lung damage in lung cancer patients treated with or without chemotherapy and cetuximab

  Hoda Sharifi; Wouter van Elmpt; Cary Oberije, Georgi Nalbantov, Marco Das, Michel Öllers, Philippe Lambin, Anne-Marie C. Dingmans, Dirk De Ruysscher

  156-162

  Published: 2016-02-01

  • PDF

• Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma

  Diana A. R. Julie, Jung Hun Oh, Aditya P. Apte, Joseph O. Deasy, Ashlyn Tom, Abraham J. Wu, Karyn A. Goodman

  208-216

  Published: 2016-02-01

  • PDF

• Erdheim-Chester disease presenting as periodontal disease: Experience of treatment with cladribine, interferon-a, local radiotherapy and anakinra

  Lena Blomstrand, Andreas Thor, Hans Hagberg

  248-250

  Published: 2016-02-01

  • PDF

• EGFR mutation testing of lung cancer patients – Experiences from Vestfold Hospital Trust

  Janna Berg, Lars Fjellbirkeland, Pål Suhrke, Peter Jebsen, Marius Lund-Iversen, Lilach Kleinberg, Lars Helgeland, Odd Terje Brustugun, Åslaug Helland

  149-155

  Published: 2016-02-01

  • PDF

• Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors

  Sarah Differding, Edmond Sterpin, Guillaume Janssens, François-Xavier Hanin, John Aldo Lee, Vincent Grégoire

  217-225

  Published: 2016-02-01

  • PDF